NEW YORK (GenomeWeb News) – Hybrigenics has acquired the yeast two-hybrid assets of Swiss biotech firm Dualsystems Biotech.

The acquisition provides Hybrigenic Services, a subsidiary of Paris-based biopharma firm Hybrigenics that specializes in protein-protein interaction work, with exclusive ownership of patented yeast two-hybrid screening technology for membrane proteins. The deal will expand the company's commercial reach in German-speaking territories, Eastern Europe, and China, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.